Serum adiponectin level in patients with benign prostatic hyperplasia

被引：0
|
作者：
Jahromi, A. Sotoodeh [1 ]
Hossaini, M. M. [1 ,2 ]
Hasanpur, A.
Inaloo, R. [1 ]
Yusefipur, A. [1 ]
Madani, A. [3 ]
Barakeh, S. [1 ]
机构：
[1] Jahrom Univ Med Sci, Jahrom, Iran
[2] Shiraz Univ Med Sci, Shiraz, Iran
[3] Hormozgan Univ Med Sci, Bandar Abbas, Iran
来源：
FEBS JOURNAL | 2010年 / 277卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：110 / 111
页数：2
相关论文
共 50 条
  • [1] Serum omentin-1 level in patients with benign prostatic hyperplasia
    He, Haiqing
    Wu, Shuiqing
    Hao, Jun
    Wang, Long
    Ai, Kai
    Zhu, Xuan
    Xu, Ran
    Zhao, Xiaokun
    Wang, Yinhuai
    Zhong, Zhaohui
    BMC UROLOGY, 2020, 20 (01)
  • [2] Serum omentin-1 level in patients with benign prostatic hyperplasia
    Haiqing He
    Shuiqing Wu
    Jun Hao
    Long Wang
    Kai Ai
    Xuan Zhu
    Ran Xu
    Xiaokun Zhao
    Yinhuai Wang
    Zhaohui Zhong
    BMC Urology, 20
  • [3] Lack of adiponectin and adiponectin receptor 1 contributes to benign prostatic hyperplasia
    Fu, Shi
    Xu, Huan
    Gu, Meng
    Liu, Chong
    Wan, Xiang
    Chen, Yanbo
    Chen, Qi
    Zhou, Juan
    Wang, Zhong
    ONCOTARGET, 2017, 8 (51) : 88537 - 88551
  • [4] Alterations in the level of trace elements in patients with benign prostatic hyperplasia
    Abul, F
    Mathew, TC
    Arun, N
    Abul, H
    Dashti, HM
    TRACE ELEMENTS AND ELECTROLYTES, 2006, 23 (02) : 119 - 123
  • [5] Serum C-reactive protein level is not associated with prostatic inflammation but with overactive detrusor in patients with benign prostatic hyperplasia
    Inamura, So
    Ito, Hideaki
    Shinagawa, Tomochika
    Tsutsumiuchi, Manami
    Taga, Minekatsu
    Tsuchiyama, Katsuki
    Kobayashi, Motohiro
    Yokoyama, Osamu
    NEUROUROLOGY AND URODYNAMICS, 2019, 38 (06) : 1728 - 1736
  • [6] SERUM C-REACTIVE PROTEIN LEVEL IS NOT ASSOCIATED WITH THE PROSTATIC INFLAMMATION BUT OVERACTIVE DETRUSOR IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
    Inamura, S.
    Ito, H.
    Tsutsumiuchi, M.
    Taga, M.
    Tsuchiyama, K.
    Matsuta, Y.
    Aoki, Y.
    Kobayashi, M.
    Yokoyama, O.
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 : S309 - S310
  • [7] Serum lipid levels in benign prostatic hyperplasia
    Murat Lekili
    Talha Müezzinoğlu
    Bekir Sami Uyanık
    Coşkun Büyüksu
    World Journal of Urology, 2006, 24 : 210 - 213
  • [8] Serum steroids in relation to benign prostatic hyperplasia
    Lagiou, P
    Mantzoros, CS
    Tzonou, A
    Signorello, LB
    Lipworth, L
    Trichopoulos, D
    ONCOLOGY, 1997, 54 (06) : 497 - 501
  • [9] SERUM HORMONE LEVELS IN BENIGN PROSTATIC HYPERPLASIA
    SKOLDEFORS, H
    BLOMSTEDT, B
    CARLSTROM, K
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1978, 12 (02): : 111 - 114
  • [10] Serum vascular endothelial growth factor C level in patients with prostate cancer and benign prostatic hyperplasia
    Voss, Martin
    Trojan, Lutz
    Steidler, Annette
    Weiss, Christel
    Grobholz, Rainer
    Alken, Peter
    Michel, Maurice Stephan
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2008, 30 (04): : 199 - 202
12345